img

Global Hormonal Contraception Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Hormonal Contraception Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Hormonal Contraception is a type of birth control that uses hormones to prevent pregnancy.
Hormonal Contraception report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Hormonal Contraception market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hospital and Clinics are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Hormonal Contraception industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Hormonal Contraception key manufacturers include Bayer AG, Merck & Co., Inc., Pfizer, Inc., Agile Therapeutics, Inc., Teva Pharmaceutical Industries Ltd., Amgen, Cipla Ltd., Glenmark Pharmaceuticals Inc. and Lupin Limited(Lupin Pharmaceuticals, Inc.), etc. Bayer AG, Merck & Co., Inc., Pfizer, Inc. are top 3 players and held % sales share in total in 2022.
Hormonal Contraception can be divided into Androgens, Estrogens, Progestrogens and Antiandrogens, etc. Androgens is the mainstream product in the market, accounting for % sales share globally in 2022.
Hormonal Contraception is widely used in various fields, such as Hospital, Clinics, Gynaecology Centers and Others, etc. Hospital provides greatest supports to the Hormonal Contraception industry development. In 2022, global % sales of Hormonal Contraception went into Hospital filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Hormonal Contraception market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Bayer AG
Merck & Co., Inc.
Pfizer, Inc.
Agile Therapeutics, Inc.
Teva Pharmaceutical Industries Ltd.
Amgen
Cipla Ltd.
Glenmark Pharmaceuticals Inc.
Lupin Limited(Lupin Pharmaceuticals, Inc.)
Novartis AG
Mylan N.V.
Johnson & Johnson
Ansell LTD
Mayer Laboratories, Inc.
Segment by Type
by Hormone
Androgens
Estrogens
Progestrogens
Antiandrogens
Gonadotropins
by Method
Combined Oral
Oral Pill
Implanted
Injected
Intrauterine
Transdermal Patch

Segment by Application


Hospital
Clinics
Gynaecology Centers
Others

Segment by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Hormonal Contraception market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Hormonal Contraception, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Hormonal Contraception industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Hormonal Contraception in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Hormonal Contraception introduction, etc. Hormonal Contraception Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Hormonal Contraception market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Hormonal Contraception Market Overview
1.1 Hormonal Contraception Product Overview
1.2 Hormonal Contraception Market Segment by Type
1.2.1 Androgens
1.2.2 Estrogens
1.2.3 Progestrogens
1.2.4 Antiandrogens
1.2.5 Gonadotropins
1.3 Global Hormonal Contraception Market Size by Type
1.3.1 Global Hormonal Contraception Market Size Overview by Type (2018-2034)
1.3.2 Global Hormonal Contraception Historic Market Size Review by Type (2018-2024)
1.3.3 Global Hormonal Contraception Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Hormonal Contraception Sales Breakdown by Type (2018-2024)
1.4.2 Europe Hormonal Contraception Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Hormonal Contraception Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Hormonal Contraception Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Hormonal Contraception Sales Breakdown by Type (2018-2024)
2 Global Hormonal Contraception Market Competition by Company
2.1 Global Top Players by Hormonal Contraception Sales (2018-2024)
2.2 Global Top Players by Hormonal Contraception Revenue (2018-2024)
2.3 Global Top Players by Hormonal Contraception Price (2018-2024)
2.4 Global Top Manufacturers Hormonal Contraception Manufacturing Base Distribution, Sales Area, Product Type
2.5 Hormonal Contraception Market Competitive Situation and Trends
2.5.1 Hormonal Contraception Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Hormonal Contraception Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Hormonal Contraception as of 2022)
2.7 Date of Key Manufacturers Enter into Hormonal Contraception Market
2.8 Key Manufacturers Hormonal Contraception Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Hormonal Contraception Status and Outlook by Region
3.1 Global Hormonal Contraception Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Hormonal Contraception Historic Market Size by Region
3.2.1 Global Hormonal Contraception Sales in Volume by Region (2018-2024)
3.2.2 Global Hormonal Contraception Sales in Value by Region (2018-2024)
3.2.3 Global Hormonal Contraception Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Hormonal Contraception Forecasted Market Size by Region
3.3.1 Global Hormonal Contraception Sales in Volume by Region (2024-2034)
3.3.2 Global Hormonal Contraception Sales in Value by Region (2024-2034)
3.3.3 Global Hormonal Contraception Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Hormonal Contraception by Application
4.1 Hormonal Contraception Market Segment by Application
4.1.1 Hospital
4.1.2 Clinics
4.1.3 Gynaecology Centers
4.1.4 Others
4.2 Global Hormonal Contraception Market Size by Application
4.2.1 Global Hormonal Contraception Market Size Overview by Application (2018-2034)
4.2.2 Global Hormonal Contraception Historic Market Size Review by Application (2018-2024)
4.2.3 Global Hormonal Contraception Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Hormonal Contraception Sales Breakdown by Application (2018-2024)
4.3.2 Europe Hormonal Contraception Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Hormonal Contraception Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Hormonal Contraception Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Hormonal Contraception Sales Breakdown by Application (2018-2024)
5 North America Hormonal Contraception by Country
5.1 North America Hormonal Contraception Historic Market Size by Country
5.1.1 North America Hormonal Contraception Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Hormonal Contraception Sales in Volume by Country (2018-2024)
5.1.3 North America Hormonal Contraception Sales in Value by Country (2018-2024)
5.2 North America Hormonal Contraception Forecasted Market Size by Country
5.2.1 North America Hormonal Contraception Sales in Volume by Country (2024-2034)
5.2.2 North America Hormonal Contraception Sales in Value by Country (2024-2034)
6 Europe Hormonal Contraception by Country
6.1 Europe Hormonal Contraception Historic Market Size by Country
6.1.1 Europe Hormonal Contraception Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Hormonal Contraception Sales in Volume by Country (2018-2024)
6.1.3 Europe Hormonal Contraception Sales in Value by Country (2018-2024)
6.2 Europe Hormonal Contraception Forecasted Market Size by Country
6.2.1 Europe Hormonal Contraception Sales in Volume by Country (2024-2034)
6.2.2 Europe Hormonal Contraception Sales in Value by Country (2024-2034)
7 Asia-Pacific Hormonal Contraception by Region
7.1 Asia-Pacific Hormonal Contraception Historic Market Size by Region
7.1.1 Asia-Pacific Hormonal Contraception Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Hormonal Contraception Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Hormonal Contraception Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Hormonal Contraception Forecasted Market Size by Region
7.2.1 Asia-Pacific Hormonal Contraception Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Hormonal Contraception Sales in Value by Region (2024-2034)
8 Latin America Hormonal Contraception by Country
8.1 Latin America Hormonal Contraception Historic Market Size by Country
8.1.1 Latin America Hormonal Contraception Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Hormonal Contraception Sales in Volume by Country (2018-2024)
8.1.3 Latin America Hormonal Contraception Sales in Value by Country (2018-2024)
8.2 Latin America Hormonal Contraception Forecasted Market Size by Country
8.2.1 Latin America Hormonal Contraception Sales in Volume by Country (2024-2034)
8.2.2 Latin America Hormonal Contraception Sales in Value by Country (2024-2034)
9 Middle East and Africa Hormonal Contraception by Country
9.1 Middle East and Africa Hormonal Contraception Historic Market Size by Country
9.1.1 Middle East and Africa Hormonal Contraception Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Hormonal Contraception Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Hormonal Contraception Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Hormonal Contraception Forecasted Market Size by Country
9.2.1 Middle East and Africa Hormonal Contraception Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Hormonal Contraception Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Bayer AG
10.1.1 Bayer AG Company Information
10.1.2 Bayer AG Introduction and Business Overview
10.1.3 Bayer AG Hormonal Contraception Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Bayer AG Hormonal Contraception Products Offered
10.1.5 Bayer AG Recent Development
10.2 Merck & Co., Inc.
10.2.1 Merck & Co., Inc. Company Information
10.2.2 Merck & Co., Inc. Introduction and Business Overview
10.2.3 Merck & Co., Inc. Hormonal Contraception Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Merck & Co., Inc. Hormonal Contraception Products Offered
10.2.5 Merck & Co., Inc. Recent Development
10.3 Pfizer, Inc.
10.3.1 Pfizer, Inc. Company Information
10.3.2 Pfizer, Inc. Introduction and Business Overview
10.3.3 Pfizer, Inc. Hormonal Contraception Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Pfizer, Inc. Hormonal Contraception Products Offered
10.3.5 Pfizer, Inc. Recent Development
10.4 Agile Therapeutics, Inc.
10.4.1 Agile Therapeutics, Inc. Company Information
10.4.2 Agile Therapeutics, Inc. Introduction and Business Overview
10.4.3 Agile Therapeutics, Inc. Hormonal Contraception Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Agile Therapeutics, Inc. Hormonal Contraception Products Offered
10.4.5 Agile Therapeutics, Inc. Recent Development
10.5 Teva Pharmaceutical Industries Ltd.
10.5.1 Teva Pharmaceutical Industries Ltd. Company Information
10.5.2 Teva Pharmaceutical Industries Ltd. Introduction and Business Overview
10.5.3 Teva Pharmaceutical Industries Ltd. Hormonal Contraception Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Teva Pharmaceutical Industries Ltd. Hormonal Contraception Products Offered
10.5.5 Teva Pharmaceutical Industries Ltd. Recent Development
10.6 Amgen
10.6.1 Amgen Company Information
10.6.2 Amgen Introduction and Business Overview
10.6.3 Amgen Hormonal Contraception Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Amgen Hormonal Contraception Products Offered
10.6.5 Amgen Recent Development
10.7 Cipla Ltd.
10.7.1 Cipla Ltd. Company Information
10.7.2 Cipla Ltd. Introduction and Business Overview
10.7.3 Cipla Ltd. Hormonal Contraception Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Cipla Ltd. Hormonal Contraception Products Offered
10.7.5 Cipla Ltd. Recent Development
10.8 Glenmark Pharmaceuticals Inc.
10.8.1 Glenmark Pharmaceuticals Inc. Company Information
10.8.2 Glenmark Pharmaceuticals Inc. Introduction and Business Overview
10.8.3 Glenmark Pharmaceuticals Inc. Hormonal Contraception Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Glenmark Pharmaceuticals Inc. Hormonal Contraception Products Offered
10.8.5 Glenmark Pharmaceuticals Inc. Recent Development
10.9 Lupin Limited(Lupin Pharmaceuticals, Inc.)
10.9.1 Lupin Limited(Lupin Pharmaceuticals, Inc.) Company Information
10.9.2 Lupin Limited(Lupin Pharmaceuticals, Inc.) Introduction and Business Overview
10.9.3 Lupin Limited(Lupin Pharmaceuticals, Inc.) Hormonal Contraception Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Lupin Limited(Lupin Pharmaceuticals, Inc.) Hormonal Contraception Products Offered
10.9.5 Lupin Limited(Lupin Pharmaceuticals, Inc.) Recent Development
10.10 Novartis AG
10.10.1 Novartis AG Company Information
10.10.2 Novartis AG Introduction and Business Overview
10.10.3 Novartis AG Hormonal Contraception Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Novartis AG Hormonal Contraception Products Offered
10.10.5 Novartis AG Recent Development
10.11 Mylan N.V.
10.11.1 Mylan N.V. Company Information
10.11.2 Mylan N.V. Introduction and Business Overview
10.11.3 Mylan N.V. Hormonal Contraception Sales, Revenue and Gross Margin (2018-2024)
10.11.4 Mylan N.V. Hormonal Contraception Products Offered
10.11.5 Mylan N.V. Recent Development
10.12 Johnson & Johnson
10.12.1 Johnson & Johnson Company Information
10.12.2 Johnson & Johnson Introduction and Business Overview
10.12.3 Johnson & Johnson Hormonal Contraception Sales, Revenue and Gross Margin (2018-2024)
10.12.4 Johnson & Johnson Hormonal Contraception Products Offered
10.12.5 Johnson & Johnson Recent Development
10.13 Ansell LTD
10.13.1 Ansell LTD Company Information
10.13.2 Ansell LTD Introduction and Business Overview
10.13.3 Ansell LTD Hormonal Contraception Sales, Revenue and Gross Margin (2018-2024)
10.13.4 Ansell LTD Hormonal Contraception Products Offered
10.13.5 Ansell LTD Recent Development
10.14 Mayer Laboratories, Inc.
10.14.1 Mayer Laboratories, Inc. Company Information
10.14.2 Mayer Laboratories, Inc. Introduction and Business Overview
10.14.3 Mayer Laboratories, Inc. Hormonal Contraception Sales, Revenue and Gross Margin (2018-2024)
10.14.4 Mayer Laboratories, Inc. Hormonal Contraception Products Offered
10.14.5 Mayer Laboratories, Inc. Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Hormonal Contraception Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Hormonal Contraception Industrial Chain Analysis
11.4 Hormonal Contraception Market Dynamics
11.4.1 Hormonal Contraception Industry Trends
11.4.2 Hormonal Contraception Market Drivers
11.4.3 Hormonal Contraception Market Challenges
11.4.4 Hormonal Contraception Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Hormonal Contraception Distributors
12.3 Hormonal Contraception Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Androgens
Table 2. Major Company of Estrogens
Table 3. Major Company of Progestrogens
Table 4. Major Company of Antiandrogens
Table 5. Major Company of Gonadotropins
Table 6. Global Hormonal Contraception Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 7. Global Hormonal Contraception Sales by Type (2018-2024) & (K Units)
Table 8. Global Hormonal Contraception Sales Market Share in Volume by Type (2018-2024)
Table 9. Global Hormonal Contraception Sales by Type (2018-2024) & (US& Million)
Table 10. Global Hormonal Contraception Market Share in Value by Type (2018-2024)
Table 11. Global Hormonal Contraception Price by Type (2018-2024) & (US$/Unit)
Table 12. Global Hormonal Contraception Sales by Type (2024-2034) & (K Units)
Table 13. Global Hormonal Contraception Sales Market Share in Volume by Type (2024-2034)
Table 14. Global Hormonal Contraception Sales by Type (2024-2034) & (US$ Million)
Table 15. Global Hormonal Contraception Sales Market Share in Value by Type (2024-2034)
Table 16. Global Hormonal Contraception Price by Type (2024-2034) & (US$/Unit)
Table 17. North America Hormonal Contraception Sales by Type (2018-2024) & (K Units)
Table 18. North America Hormonal Contraception Sales by Type (2018-2024) & (US$ Million)
Table 19. Europe Hormonal Contraception Sales (K Units) by Type (2018-2024)
Table 20. Europe Hormonal Contraception Sales by Type (2018-2024) & (US$ Million)
Table 21. Asia-Pacific Hormonal Contraception Sales (K Units) by Type (2018-2024)
Table 22. Asia-Pacific Hormonal Contraception Sales by Type (2018-2024) & (US$ Million)
Table 23. Latin America Hormonal Contraception Sales (K Units) by Type (2018-2024)
Table 24. Latin America Hormonal Contraception Sales by Type (2018-2024) & (US$ Million)
Table 25. Middle East and Africa Hormonal Contraception Sales (K Units) by Type (2018-2024)
Table 26. Middle East and Africa Hormonal Contraception Sales by Type (2018-2024) & (US$ Million)
Table 27. Global Hormonal Contraception Sales by Company (2018-2024) & (K Units)
Table 28. Global Hormonal Contraception Sales Share by Company (2018-2024)
Table 29. Global Hormonal Contraception Revenue by Company (2018-2024) & (US$ Million)
Table 30. Global Hormonal Contraception Revenue Share by Company (2018-2024)
Table 31. Global Market Hormonal Contraception Price by Company (2018-2024) & (US$/Unit)
Table 32. Global Hormonal Contraception Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 33. Global Hormonal Contraception Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 34. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Hormonal Contraception as of 2022)
Table 35. Date of Key Manufacturers Enter into Hormonal Contraception Market
Table 36. Key Manufacturers Hormonal Contraception Product Type
Table 37. Mergers & Acquisitions, Expansion Plans
Table 38. Global Hormonal Contraception Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 39. Global Hormonal Contraception Sales by Region (2018-2024) & (K Units)
Table 40. Global Hormonal Contraception Sales Market Share in Volume by Region (2018-2024)
Table 41. Global Hormonal Contraception Sales by Region (2018-2024) & (US$ Million)
Table 42. Global Hormonal Contraception Sales Market Share in Value by Region (2018-2024)
Table 43. Global Hormonal Contraception Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 44. Global Hormonal Contraception Sales by Region (2024-2034) & (K Units)
Table 45. Global Hormonal Contraception Sales Market Share in Volume by Region (2024-2034)
Table 46. Global Hormonal Contraception Sales by Region (2024-2034) & (US$ Million)
Table 47. Global Hormonal Contraception Sales Market Share in Value by Region (2024-2034)
Table 48. Global Hormonal Contraception Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2034)
Table 49. Global Hormonal Contraception Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 50. Global Hormonal Contraception Sales by Application (2018-2024) & (K Units)
Table 51. Global Hormonal Contraception Sales Market Share in Volume by Application (2018-2024)
Table 52. Global Hormonal Contraception Sales by Application (2018-2024) & (US$ Million)
Table 53. Global Hormonal Contraception Sales Market Share in Value by Application (2018-2024)
Table 54. Global Hormonal Contraception Price by Application (2018-2024) & (US$/Unit)
Table 55. Global Hormonal Contraception Sales by Application (2024-2034) & (K Units)
Table 56. Global Hormonal Contraception Sales Market Share in Volume by Application (2024-2034)
Table 57. Global Hormonal Contraception Sales by Application (2024-2034) & (US$ Million)
Table 58. Global Hormonal Contraception Sales Market Share in Value by Application (2024-2034)
Table 59. Global Hormonal Contraception Price by Application (2024-2034) & (US$/Unit)
Table 60. North America Hormonal Contraception Sales by Application (2018-2024) (K Units)
Table 61. North America Hormonal Contraception Sales by Application (2018-2024) & (US$ Million)
Table 62. Europe Hormonal Contraception Sales by Application (2018-2024) (K Units)
Table 63. Europe Hormonal Contraception Sales by Application (2018-2024) & (US$ Million)
Table 64. Asia-Pacific Hormonal Contraception Sales by Application (2018-2024) (K Units)
Table 65. Asia-Pacific Hormonal Contraception Sales by Application (2018-2024) & (US$ Million)
Table 66. Latin America Hormonal Contraception Sales by Application (2018-2024) (K Units)
Table 67. Latin America Hormonal Contraception Sales by Application (2018-2024) & (US$ Million)
Table 68. Middle East and Africa Hormonal Contraception Sales by Application (2018-2024) (K Units)
Table 69. Middle East and Africa Hormonal Contraception Sales by Application (2018-2024) & (US$ Million)
Table 70. North America Hormonal Contraception Sales by Country (2018-2024) & (K Units)
Table 71. North America Hormonal Contraception Sales Market Share in Volume by Country (2018-2024)
Table 72. North America Hormonal Contraception Sales by Country (2018-2024) & (US$ Million)
Table 73. North America Hormonal Contraception Sales Market Share in Value by Country (2018-2024)
Table 74. North America Hormonal Contraception Sales by Country (2024-2034) & (K Units)
Table 75. North America Hormonal Contraception Sales Market Share in Volume by Country (2024-2034)
Table 76. North America Hormonal Contraception Sales by Country (2024-2034) & (US$ Million)
Table 77. North America Hormonal Contraception Sales Market Share in Value by Country (2024-2034)
Table 78. Europe Hormonal Contraception Sales by Country (2018-2024) & (K Units)
Table 79. Europe Hormonal Contraception Sales Market Share in Volume by Country (2018-2024)
Table 80. Europe Hormonal Contraception Sales by Country (2018-2024) & (US$ Million)
Table 81. Europe Hormonal Contraception Sales Market Share in Value by Country (2018-2024)
Table 82. Europe Hormonal Contraception Sales by Country (2024-2034) & (K Units)
Table 83. Europe Hormonal Contraception Sales Market Share in Volume by Country (2024-2034)
Table 84. Europe Hormonal Contraception Sales by Country (2024-2034) & (US$ Million)
Table 85. Europe Hormonal Contraception Sales Market Share in Value by Country (2024-2034)
Table 86. Asia-Pacific Hormonal Contraception Sales by Region (2018-2024) & (K Units)
Table 87. Asia-Pacific Hormonal Contraception Sales Market Share in Volume by Region (2018-2024)
Table 88. Asia-Pacific Hormonal Contraception Sales by Region (2018-2024) & (US$ Million)
Table 89. Asia-Pacific Hormonal Contraception Sales Market Share in Value by Region (2018-2024)
Table 90. Asia-Pacific Hormonal Contraception Sales by Region (2024-2034) & (K Units)
Table 91. Asia-Pacific Hormonal Contraception Sales Market Share in Volume by Region (2024-2034)
Table 92. Asia-Pacific Hormonal Contraception Sales by Region (2024-2034) & (US$ Million)
Table 93. Asia-Pacific Hormonal Contraception Sales Market Share in Value by Region (2024-2034)
Table 94. Latin America Hormonal Contraception Sales by Country (2018-2024) & (K Units)
Table 95. Latin America Hormonal Contraception Sales Market Share in Volume by Country (2018-2024)
Table 96. Latin America Hormonal Contraception Sales by Country (2018-2024) & (US$ Million)
Table 97. Latin America Hormonal Contraception Sales Market Share in Value by Country (2018-2024)
Table 98. Latin America Hormonal Contraception Sales by Country (2024-2034) & (K Units)
Table 99. Latin America Hormonal Contraception Sales Market Share in Volume by Country (2024-2034)
Table 100. Latin America Hormonal Contraception Sales by Country (2024-2034) & (US$ Million)
Table 101. Latin America Hormonal Contraception Sales Market Share in Value by Country (2024-2034)
Table 102. Middle East and Africa Hormonal Contraception Sales by Country (2018-2024) & (K Units)
Table 103. Middle East and Africa Hormonal Contraception Sales Market Share in Volume by Country (2018-2024)
Table 104. Middle East and Africa Hormonal Contraception Sales by Country (2018-2024) & (US$ Million)
Table 105. Middle East and Africa Hormonal Contraception Sales Market Share in Value by Country (2018-2024)
Table 106. Middle East and Africa Hormonal Contraception Sales by Country (2024-2034) & (K Units)
Table 107. Middle East and Africa Hormonal Contraception Sales Market Share in Volume by Country (2024-2034)
Table 108. Middle East and Africa Hormonal Contraception Sales by Country (2024-2034) & (US$ Million)
Table 109. Middle East and Africa Hormonal Contraception Sales Market Share in Value by Country (2024-2034)
Table 110. Bayer AG Company Information
Table 111. Bayer AG Introduction and Business Overview
Table 112. Bayer AG Hormonal Contraception Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 113. Bayer AG Hormonal Contraception Product
Table 114. Bayer AG Recent Development
Table 115. Merck & Co., Inc. Company Information
Table 116. Merck & Co., Inc. Introduction and Business Overview
Table 117. Merck & Co., Inc. Hormonal Contraception Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 118. Merck & Co., Inc. Hormonal Contraception Product
Table 119. Merck & Co., Inc. Recent Development
Table 120. Pfizer, Inc. Company Information
Table 121. Pfizer, Inc. Introduction and Business Overview
Table 122. Pfizer, Inc. Hormonal Contraception Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 123. Pfizer, Inc. Hormonal Contraception Product
Table 124. Pfizer, Inc. Recent Development
Table 125. Agile Therapeutics, Inc. Company Information
Table 126. Agile Therapeutics, Inc. Introduction and Business Overview
Table 127. Agile Therapeutics, Inc. Hormonal Contraception Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 128. Agile Therapeutics, Inc. Hormonal Contraception Product
Table 129. Agile Therapeutics, Inc. Recent Development
Table 130. Teva Pharmaceutical Industries Ltd. Company Information
Table 131. Teva Pharmaceutical Industries Ltd. Introduction and Business Overview
Table 132. Teva Pharmaceutical Industries Ltd. Hormonal Contraception Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 133. Teva Pharmaceutical Industries Ltd. Hormonal Contraception Product
Table 134. Teva Pharmaceutical Industries Ltd. Recent Development
Table 135. Amgen Company Information
Table 136. Amgen Introduction and Business Overview
Table 137. Amgen Hormonal Contraception Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 138. Amgen Hormonal Contraception Product
Table 139. Amgen Recent Development
Table 140. Cipla Ltd. Company Information
Table 141. Cipla Ltd. Introduction and Business Overview
Table 142. Cipla Ltd. Hormonal Contraception Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 143. Cipla Ltd. Hormonal Contraception Product
Table 144. Cipla Ltd. Recent Development
Table 145. Glenmark Pharmaceuticals Inc. Company Information
Table 146. Glenmark Pharmaceuticals Inc. Introduction and Business Overview
Table 147. Glenmark Pharmaceuticals Inc. Hormonal Contraception Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 148. Glenmark Pharmaceuticals Inc. Hormonal Contraception Product
Table 149. Glenmark Pharmaceuticals Inc. Recent Development
Table 150. Lupin Limited(Lupin Pharmaceuticals, Inc.) Company Information
Table 151. Lupin Limited(Lupin Pharmaceuticals, Inc.) Introduction and Business Overview
Table 152. Lupin Limited(Lupin Pharmaceuticals, Inc.) Hormonal Contraception Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 153. Lupin Limited(Lupin Pharmaceuticals, Inc.) Hormonal Contraception Product
Table 154. Lupin Limited(Lupin Pharmaceuticals, Inc.) Recent Development
Table 155. Novartis AG Company Information
Table 156. Novartis AG Introduction and Business Overview
Table 157. Novartis AG Hormonal Contraception Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 158. Novartis AG Hormonal Contraception Product
Table 159. Novartis AG Recent Development
Table 160. Mylan N.V. Company Information
Table 161. Mylan N.V. Introduction and Business Overview
Table 162. Mylan N.V. Hormonal Contraception Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 163. Mylan N.V. Hormonal Contraception Product
Table 164. Mylan N.V. Recent Development
Table 165. Johnson & Johnson Company Information
Table 166. Johnson & Johnson Introduction and Business Overview
Table 167. Johnson & Johnson Hormonal Contraception Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 168. Johnson & Johnson Hormonal Contraception Product
Table 169. Johnson & Johnson Recent Development
Table 170. Ansell LTD Company Information
Table 171. Ansell LTD Introduction and Business Overview
Table 172. Ansell LTD Hormonal Contraception Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 173. Ansell LTD Hormonal Contraception Product
Table 174. Ansell LTD Recent Development
Table 175. Mayer Laboratories, Inc. Company Information
Table 176. Mayer Laboratories, Inc. Introduction and Business Overview
Table 177. Mayer Laboratories, Inc. Hormonal Contraception Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 178. Mayer Laboratories, Inc. Hormonal Contraception Product
Table 179. Mayer Laboratories, Inc. Recent Development
Table 180. Key Raw Materials Lists
Table 181. Raw Materials Key Suppliers Lists
Table 182. Hormonal Contraception Market Trends
Table 183. Hormonal Contraception Market Drivers
Table 184. Hormonal Contraception Market Challenges
Table 185. Hormonal Contraception Market Restraints
Table 186. Hormonal Contraception Distributors List
Table 187. Hormonal Contraception Downstream Customers
Table 188. Research Programs/Design for This Report
Table 189. Key Data Information from Secondary Sources
Table 190. Key Data Information from Primary Sources
List of Figures
Figure 1. Hormonal Contraception Product Picture
Figure 2. Global Hormonal Contraception Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Hormonal Contraception Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Hormonal Contraception Sales Status and Outlook (2018-2034) & (K Units)
Figure 5. Product Picture of Androgens
Figure 6. Global by Hormone Sales YoY Growth (2018-2034) & (K Units)
Figure 7. Product Picture of Estrogens
Figure 8. Global by Method Sales YoY Growth (2018-2034) & (K Units)
Figure 9. Product Picture of Progestrogens
Figure 10. Global Progestrogens Sales YoY Growth (2018-2034) & (K Units)
Figure 11. Product Picture of Antiandrogens
Figure 12. Global Antiandrogens Sales YoY Growth (2018-2034) & (K Units)
Figure 13. Product Picture of Gonadotropins
Figure 14. Global Gonadotropins Sales YoY Growth (2018-2034) & (K Units)
Figure 15. Global Hormonal Contraception Sales by Type (2018-2034) & (US$ Million)
Figure 16. Global Hormonal Contraception Sales Market Share by Type in 2022 & 2034
Figure 17. North America Hormonal Contraception Sales Market Share in Volume by Type in 2022
Figure 18. North America Hormonal Contraception Sales Market Share in Value by Type in 2022
Figure 19. Europe Hormonal Contraception Sales Market Share in Volume by Type in 2022
Figure 20. Europe Hormonal Contraception Sales Market Share in Value by Type in 2022
Figure 21. Asia-Pacific Hormonal Contraception Sales Market Share in Volume by Type in 2022
Figure 22. Asia-Pacific Hormonal Contraception Sales Market Share in Value by Type in 2022
Figure 23. Latin America Hormonal Contraception Sales Market Share in Volume by Type in 2022
Figure 24. Latin America Hormonal Contraception Sales Market Share in Value by Type in 2022
Figure 25. Middle East and Africa Hormonal Contraception Sales Market Share in Volume by Type in 2022
Figure 26. Middle East and Africa Hormonal Contraception Sales Market Share in Value by Type in 2022
Figure 27. The 5 and 10 Largest Manufacturers in the World: Market Share by Hormonal Contraception Sales in 2022
Figure 28. The 5 and 10 Largest Manufacturers in the World: Market Share by Hormonal Contraception Revenue in 2022
Figure 29. Hormonal Contraception Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 30. Product Picture of Hospital
Figure 31. Global Hospital Sales YoY Growth (2018-2034) & (K Units)
Figure 32. Product Picture of Clinics
Figure 33. Global Clinics Sales YoY Growth (2018-2034) & (K Units)
Figure 34. Product Picture of Gynaecology Centers
Figure 35. Global Gynaecology Centers Sales YoY Growth (2018-2034) & (K Units)
Figure 36. Product Picture of Others
Figure 37. Global Others Sales YoY Growth (2018-2034) & (K Units)
Figure 38. Global Hormonal Contraception Sales by Application (2018-2034) & (US$ Million)
Figure 39. Global Hormonal Contraception Sales Market Share by Application in 2022 & 2034
Figure 40. North America Hormonal Contraception Sales Market Share in Volume by Application in 2022
Figure 41. North America Hormonal Contraception Sales Market Share in Value by Application in 2022
Figure 42. Europe Hormonal Contraception Sales Market Share in Volume by Application in 2022
Figure 43. Europe Hormonal Contraception Sales Market Share in Value by Application in 2022
Figure 44. Asia-Pacific Hormonal Contraception Sales Market Share in Volume by Application in 2022
Figure 45. Asia-Pacific Hormonal Contraception Sales Market Share in Value by Application in 2022
Figure 46. Latin America Hormonal Contraception Sales Market Share in Volume by Application in 2022
Figure 47. Latin America Hormonal Contraception Sales Market Share in Value by Application in 2022
Figure 48. Middle East and Africa Hormonal Contraception Sales Market Share in Value by Application in 2022
Figure 49. Key Raw Materials Price
Figure 50. Hormonal Contraception Manufacturing Cost Structure
Figure 51. Hormonal Contraception Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed